Indeed, in 10–30% of patients with a clinical diagnosis of MEN1 syndrome, no pathogenic MEN1 variant is found, and it has been suggested that re-analysis of these patients might be beneficial [45]. The gene discussed is MEN1; the disease is multiple endocrine neoplasia type 1.